The State-of-TRT 2026: Helping APPs & Their Patients Manage TRT, Not Just Start It
Inaugural Landmark APP Study, Conducted in Partnership with SERMO
Saturday, October 10, 2026
7:00 AM - 8:00 AM
Program Objectives:
- Review key market trends from the inaugural study of more than 200 U.S. advanced practice providers (APPs) experienced in testosterone replacement therapy (TRT)
- Explore how guideline usage varies between APPs and implications for TRT management
- Discuss how the removal of the testosterone Black Box Warning may be influencing clinical decision making
- Discuss upcoming regulatory changes to TRT and implications for healthcare professionals and patients
Basil Z. Kaaki, DMSc, PA-CSpeaker
Assistant Professor,
Program Director: APP Men's Health and Sexual Medicine Preceptorship, Scott Department of Urology, Baylor College of Medicine
Houston, Texas
Program Director: APP Men's Health and Sexual Medicine Preceptorship, Scott Department of Urology, Baylor College of Medicine
Houston, Texas
Patrick Dougherty, MPAS, PA-CSpeaker
Physician Assistant
UT Southwestern Medical Center, Department of Urology
Dallas, Texas
UT Southwestern Medical Center, Department of Urology
Dallas, Texas
Charity L. Gardner, APRN-FNP-CSpeaker
Nurse Practitioner
Amarillo Urology Associates
Amarillo, Texas
Amarillo Urology Associates
Amarillo, Texas
Henry M. Vanpala, DNP, AGNP-CSpeaker
Nurse Practitioner
North Hills Internal & Integrative Medicine
Raleigh, NC
North Hills Internal & Integrative Medicine
Raleigh, NC
Attention: Restrictions on use of SMSNA content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Subscribe for our Newsletter!
